2021
DOI: 10.1016/j.nutres.2021.08.007
|View full text |Cite
|
Sign up to set email alerts
|

Mechanistic basis and preliminary practice of butyric acid and butyrate sodium to mitigate gut inflammatory diseases: a comprehensive review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
16
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 26 publications
(16 citation statements)
references
References 183 publications
0
16
0
Order By: Relevance
“…Several studies had indicated that butyric acid participated in adipose differentiation and could hydrolyze triglyceride-rich lipoproteins, thus, the increase of butyric acid is beneficial to the lipid homeostasis across biological system (Cardona et al, 2018; He & Moreau, 2019 ). Studies had shown a link between reduced butyric acid content and gastrointestinal diseases ( Zhang, Wang, Zhao, Liu, Wang, & Zhou, 2021 ). In this study, increased abundances of butyrate-producing bacteria, such as Bacteroides , Lactobacillus , unclassified f Lachnospiraceae , and Blautia, demonstrate that cinnamaldehyde microcapsules may influence the makeup of the gut microbiota to affect SCFA synthesis.…”
Section: Resultsmentioning
confidence: 99%
“…Several studies had indicated that butyric acid participated in adipose differentiation and could hydrolyze triglyceride-rich lipoproteins, thus, the increase of butyric acid is beneficial to the lipid homeostasis across biological system (Cardona et al, 2018; He & Moreau, 2019 ). Studies had shown a link between reduced butyric acid content and gastrointestinal diseases ( Zhang, Wang, Zhao, Liu, Wang, & Zhou, 2021 ). In this study, increased abundances of butyrate-producing bacteria, such as Bacteroides , Lactobacillus , unclassified f Lachnospiraceae , and Blautia, demonstrate that cinnamaldehyde microcapsules may influence the makeup of the gut microbiota to affect SCFA synthesis.…”
Section: Resultsmentioning
confidence: 99%
“…34 In humans, butyrate is consistently not detected in peripheral blood, suggesting it is absorbed and completely metabolised either in the intestine mucosa or in the liver. 20 Following cell uptake, butyrate enters the mitochondrial fatty acid oxidation pathway and its product acetyl-CoA enters the TCA cycle, being converted to citrate and then oxaloacetate, ending up as triose-phosphate to be used for glucose synthesis 37,38 (Figure 1). Butyrate can also be metabolised to other fatty acids, cholesterol and ketone bodies.…”
Section: Butyric Acid-metabolism and Biological Functionsmentioning
confidence: 99%
“…Following cell uptake, butyrate enters the mitochondrial fatty acid oxidation pathway and its product acetyl‐CoA enters the TCA cycle, being converted to citrate and then oxaloacetate, ending up as triose‐phosphate to be used for glucose synthesis 37,38 (Figure 1). Butyrate can also be metabolised to other fatty acids, cholesterol and ketone bodies 38 …”
Section: Butyric Acid and Derivate Forms—characterisationmentioning
confidence: 99%
“…Under normal circumstances, the response process is temporary. However, if the infection and the elimination of damage factors do not disappear or the damage factors exist for a long time, a pathological chronic inflammatory process precede (Zhang et al., 2021), such as that involved in the occurrence of many diseases (insulin resistance and T2DM) (J. Guo & Fu, 2020; Serrano‐Lopez et al., 2021). It is hypothesized that the decrease in total lymphocytes, CD4 + , and CD4 + /CD8 + T cells are an important feature of immunodeficiency.…”
Section: Introductionmentioning
confidence: 99%